Prof. Dr. Andrea Henze

Curriculum vitae

seit 01/2021 Professur Ernährungsphysiologie (Martin-Luther-Universität Halle-Wittenberg)

seit 03/2018 Leiterin der BMBF-geförderten Nachwuchsgruppe ProAID (Protein oxidation in aging as target for an individualized dietary intervention)

03/2017 bis 02/2018 DFG-Forschungsstipendium in der Protein Research Group des Department of Biochemistry and Molecular Biology an der University of Southern Denmark, Odense, Dänemark

01/2005 bis 02/2017 akademische Mitarbeiterin am Lehrstuhl für Physiologie und Pathophysiologie der Ernährung, Institut für Ernährungswissenschaft der Universität Potsdam

01/2005 bis 12/2009 Promotion am Institut für Ernährungswissenschaft der Universität Potsdam zum Thema „Chronic kidney disease and type 2 diabetes mellitus as factors influencing retinol-binding protein 4“

10/1999 bis 12/2004 Studium der Ernährungswissenschaft an der Universität Potsdam, Diplom

Publikationen

R. Auyyuenyong, A. Henze, J. Ungru, F. J. Schweigert, J. Raila and I. Vervuert (2018). Determination of lipid profiles in serum of obese ponies before and after weight reduction by using multi-one-dimensional thin-layer chromatography. Res Vet Sci, 117: 111-117

M. Alicke, J. K. Boakye-Appiah, I. Abdul-Jalil, A. Henze, M. van der Giet, M. B. Schulze, F. J. Schweigert, F. P. Mockenhaupt, G. Bedu-Addo and I. Danquah (2017). Adolescent health in rural Ghana: A cross-sectional study on the co-occurrence of infectious diseases, malnutrition and cardio-metabolic risk factors. PLoS One, 12: e0180436

A. Henze, T. Homann, I. Rohn, M. Aschner, C. D. Link, B. Kleuser, F. J. Schweigert, T. Schwerdtle and J. Bornhorst (2016). Caenorhabditis elegans as a model system to study post-translational modifications of human transthyretin. Sci Rep, 6: 37346

S. Reeg, T. Jung, J. P. Castro, K. J. A. Davies, A. Henze and T. Grune (2016). The molecular chaperone Hsp70 promotes the proteolytic removal of oxidatively damaged proteins by the proteasome. Free Radic Biol Med, 99: 153-166

I. Danquah, C. L. Dobrucky, L. K. Frank, A. Henze, Y. A. Amoako, G. Bedu-Addo, J. Raila, M. B. Schulze, F. P. Mockenhaupt and F. J. Schweigert (2015). Vitamin A: potential misclassification of vitamin A status among patients with type 2 diabetes and hypertension in urban Ghana. Am, 102: 207-14. doi: 10.3945/ajcn.114.101345. Epub 2015 May 27.

A. Fruscalzo, A. P. Londero, L. Driul, A. Henze, L. Tonutti, M. Ceraudo, G. Zanotti, R. Berni, F. J. Schweigert and J. Raila (2015). First trimester concentrations of the TTR-RBP4-retinol complex components as early markers of insulin-treated gestational diabetes mellitus. Clin Chem Lab Med, 53: 1643-51

A. Henze, T. Homann, M. Serteser, O. Can, O. Sezgin, A. Coskun, I. Unsal, F. J. Schweigert and A. Ozpinar (2015). Post-translational modifications of transthyretin affect the triiodonine-binding potential. J Cell Mol Med, 19: 359-370. Epub 2014 Oct 14.

K. Frede, A. Henze, M. Khalil, S. Baldermann, F. J. Schweigert and H. Rawel (2014). Stability and cellular uptake of lutein-loaded emulsions. J Funct Foods, 8: 118-127

K. M. Espe, J. Raila, A. Henze, K. Blouin, A. Schneider, D. Schmiedeke, V. Krane, S. Pilz, F. J. Schweigert, B. Hocher, C. Wanner and C. Drechsler (2013). Low Plasma alpha-Tocopherol Concentrations and Adverse Clinical Outcomes in Diabetic Hemodialysis Patients. Clin J Am Soc Nephrol, 8: 452-458

A. Henze, J. Raila, A. Scholze, W. Zidek, M. Tepel and F. J. Schweigert (2013). Does N-acetylcysteine modulate posttranslational modifications of transthyretin in hemodialysis patients? Antioxid Redox Signal, 19: 1166-1172

M. Muenzner, N. Tuvia, C. Deutschmann, N. Witte, A. Tolkachov, A. Valai, A. Henze, L. E. Sander, J. Raila and M. Schupp (2013). Retinol-Binding Protein 4 and Its Membrane Receptor STRA6 Control Adipogenesis by Regulating Cellular Retinoid Homeostasis and Retinoic Acid Receptor alpha Activity. Mol Cell Biol, 33: 4068-82

M. L. Alter, I. M. Ott, K. von Websky, O. Tsuprykov, Y. Sharkovska, K. Krause-Relle, J. Raila, A. Henze, T. Klein and B. Hocher (2012). DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy. Kidney Blood Press Res, 36: 119-130

A. Henze, K. M. Espe, C. Wanner, V. Krane, J. Raila, B. Hocher, F. J. Schweigert and C. Drechsler (2012). Transthyretin Predicts Cardiovascular Outcome in Hemodialysis Patients With Type 2 Diabetes. Diabetes Care, 35: 2365-72

I. M. Ott, M. L. Alter, K. von Websky, A. Kretschmer, O. Tsuprykov, Y. Sharkovska, K. Krause-Relle, J. Raila, A. Henze, J. P. Stasch and B. Hocher (2012). Effects of Stimulation of Soluble Guanylate Cyclase on Diabetic Nephropathy in Diabetic eNOS Knockout Mice on Top of Angiotensin II Receptor Blockade. PLoS One, 7: e42623

K. M. Espe, J. Raila, A. Henze, V. Krane, F. J. Schweigert, B. Hocher, C. Wanner and C. Drechsler (2011). Impact of vitamin A on clinical outcomes in haemodialysis patients. Nephrol Dial Transplant, 26: 4054-61

A. Henze, F. Aumer, A. Grabner, J. Raila and F. J. Schweigert (2011). Genetic differences in the serum proteome of horses, donkeys and mules are detectable by protein profiling. Br J Nutr, 106 Suppl 1: S170-3

A. Henze, J. Raila, C. Kempf, P. Reinke, A. Sefrin, U. Querfeld and F. J. Schweigert (2011). Vitamin A metabolism is changed in donors after living-kidney transplantation: An observational study. Lipids Health Dis, 10: 231

K. Thawnashom, R. Tungtrongchitr, S. Chanchay, A. Tungtrongchitr, J. Raila, A. Henze and F. J. Schweigert (2011). Association between retinol-binding protein and renal function among Asian subjects with type 2 diabetes mellitus: A cross-sectional study. Southeast Asian J Trop Med Public Health, 42: 1-10

T. Bobbert, J. Raila, F. Schwarz, K. Mai, A. Henze, A. F. Pfeiffer, F. J. Schweigert and J. Spranger (2010). Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis, 213: 549-551

A. Henze, S. K. Frey, J. Raila, A. Scholze, J. Spranger, M. O. Weickert, M. Tepel, W. Zidek and F. J. Schweigert (2010). Alterations of retinol-binding protein 4 species in patients with different stages of chronic kidney disease and their relation to lipid parameters. Biochem Biophys Res Commun, 393: 79-83

S. K. Frey, J. Spranger, A. Henze, A. F. Pfeiffer, F. J. Schweigert and J. Raila (2009). Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus. Metabolism, 58: 1386-92

S. K. Frey, A. Henze, B. Nagl, J. Raila, A. Scholze, M. Tepel, F. J. Schweigert and W. Zidek (2008). Effect of renal replacement therapy on retinol-binding protein 4 isoforms. Clin Chim Acta, 401: 46-50

S. K. Frey, B. Nagl, A. Henze, J. Raila, B. Schlosser, T. Berg, M. Tepel, W. Zidek, M. O. Weickert, A. F. Pfeiffer and F. J. Schweigert (2008). Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver. Lipids Health Dis, 7: 29

A. Henze, S. K. Frey, J. Raila, M. Tepel, A. Scholze, A. F. Pfeiffer, M. O. Weickert, J. Spranger and F. J. Schweigert (2008). Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes, 57: 3323-6

A. Henze, S. Rohn, B. Gericke, J. Raila and F. J. Schweigert (2008). Structural modifications of serum transthyretin in rats during protein-energy malnutrition. Rapid Commun Mass Spectrom, 22: 3270-3274

J. Raila, A. Henze, J. Spranger, M. Mohlig, A. F. Pfeiffer and F. J. Schweigert (2007). Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients. Kidney Int, 72: 505-511